Your session is about to expire
← Back to Search
Assessment of Day-night Secretion of Progesterone and LH Across Puberty (LH Trial)
N/A
Recruiting
Led By Christopher R. McCartney, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether too much testosterone in the blood can cause problems with other hormones that can lead to the development of polycystic ovary syndrome (PCOS).
Eligible Conditions
- Puberty
- Androgen Syndrome
- Polycystic ovary syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: HyperandrogenemiaExperimental Treatment1 Intervention
Peripubertal girls with hyperandrogenemia
Group II: ControlsExperimental Treatment1 Intervention
Peripubertal girls without hyperandrogenemia
Find a Location
Who is running the clinical trial?
University of VirginiaLead Sponsor
785 Previous Clinical Trials
1,316,371 Total Patients Enrolled
4 Trials studying Puberty
165 Patients Enrolled for Puberty
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,632 Total Patients Enrolled
3 Trials studying Puberty
129 Patients Enrolled for Puberty
Christopher R. McCartney, MDPrincipal InvestigatorUniversity of Virginia
3 Previous Clinical Trials
30 Total Patients Enrolled